ATE328276T1 - Verfahren zur identifizierung von liganden eines biologischen substrats - Google Patents

Verfahren zur identifizierung von liganden eines biologischen substrats

Info

Publication number
ATE328276T1
ATE328276T1 AT02705752T AT02705752T ATE328276T1 AT E328276 T1 ATE328276 T1 AT E328276T1 AT 02705752 T AT02705752 T AT 02705752T AT 02705752 T AT02705752 T AT 02705752T AT E328276 T1 ATE328276 T1 AT E328276T1
Authority
AT
Austria
Prior art keywords
biological substrate
identifying ligands
binding
compound
binds
Prior art date
Application number
AT02705752T
Other languages
English (en)
Inventor
Mathai Mammen
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Application granted granted Critical
Publication of ATE328276T1 publication Critical patent/ATE328276T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
AT02705752T 2001-01-11 2002-01-10 Verfahren zur identifizierung von liganden eines biologischen substrats ATE328276T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/758,916 US6656694B2 (en) 2001-01-11 2001-01-11 Method for identifying a ligand for a biological substrate

Publications (1)

Publication Number Publication Date
ATE328276T1 true ATE328276T1 (de) 2006-06-15

Family

ID=25053626

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02705752T ATE328276T1 (de) 2001-01-11 2002-01-10 Verfahren zur identifizierung von liganden eines biologischen substrats

Country Status (7)

Country Link
US (1) US6656694B2 (de)
EP (1) EP1350108B1 (de)
JP (1) JP4111830B2 (de)
AT (1) ATE328276T1 (de)
AU (1) AU2002239882A1 (de)
DE (1) DE60211849T2 (de)
WO (1) WO2002056016A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020172967A1 (en) * 2001-02-13 2002-11-21 Gadek Thomas R. Identification of non-covalent complexes by mass spectrometry
WO2005007645A1 (en) * 2003-07-11 2005-01-27 Theravance, Inc. Substituted 4-amino-1-benzylpiperidine compounds
JP2007528415A (ja) * 2004-03-11 2007-10-11 セラヴァンス， インコーポレーテッド ムスカリンレセプターアンタゴニストとしての有用なビフェニル化合物
JP2007528413A (ja) * 2004-03-11 2007-10-11 セラヴァンス， インコーポレーテッド ムスカリンレセプターアンタゴニストとしての有用なビフェニル化合物
WO2005087733A1 (en) * 2004-03-11 2005-09-22 Theravance, Inc. Biphenyl compounds useful as muscarinic receptor antagonists
TW200538095A (en) * 2004-03-11 2005-12-01 Theravance Inc Biphenyl compounds useful as muscarinic receptor antagonists
TWI341836B (en) 2004-03-11 2011-05-11 Theravance Inc Biphenyl compounds useful as muscarinic receptor antagonists
US7456199B2 (en) * 2004-03-11 2008-11-25 Theravance, Inc. Biphenyl compounds useful as muscarinic receptor antagonists
EP1723115A1 (de) * 2004-03-11 2006-11-22 Theravance, Inc. Als muscarinrezeptorantagonisten geeignete biphenylverbindungen
US7262205B2 (en) 2004-03-11 2007-08-28 Theravance, Inc. Biphenyl compounds useful as muscarinic receptor antagonists
US20060052943A1 (en) * 2004-07-28 2006-03-09 Karthik Ramani Architectures, queries, data stores, and interfaces for proteins and drug molecules
EP1866284A1 (de) * 2005-03-10 2007-12-19 Theravance, Inc. Biphenylverbindungen als muskarinrezeptorantagonisten
EP1856112A1 (de) * 2005-03-10 2007-11-21 Theravance, Inc. Biphenylverbindungen als muscarinrezeptor-antagonisten
WO2006099031A1 (en) * 2005-03-10 2006-09-21 Theravance, Inc. Biphenyl compounds useful as muscarinic receptor antagonists
US7659403B2 (en) * 2005-03-10 2010-02-09 Theravance, Inc. Biphenyl compounds useful as muscarinic receptor antagonists
TW200714587A (en) * 2005-03-10 2007-04-16 Theravance Inc Biphenyl compounds useful as muscarinic receptor antagonists
WO2006138218A1 (en) * 2005-06-13 2006-12-28 Theravance, Inc. Biphenyl compounds useful as muscarinic receptor antagonists
JP7305148B2 (ja) 2019-02-01 2023-07-10 元旦ビューティ工業株式会社 樋受け構造、及びその施工法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3882904T2 (de) 1987-09-30 1993-11-18 Beckman Instruments Inc Aus zwei Verzahnungen bestehendes Konjugat und Verfahren zu seiner Verwendung.
EP0593956B1 (de) 1992-10-21 2002-02-13 Dade Behring Inc. Agglutinationstest unter Anwendung eines multivalenten Liganden
US5698401A (en) 1995-11-14 1997-12-16 Abbott Laboratories Use of nuclear magnetic resonance to identify ligands to target biomolecules
EP0901629A4 (de) 1996-03-21 2000-02-02 Univ Princeton Kohlenhydratbibliothek, assay und methode
US6011137A (en) 1996-04-03 2000-01-04 University Of North Carolina At Chapel Hill Identification and isolation of novel polypeptides having WW domains and methods of using same
WO1999025384A2 (en) 1997-11-17 1999-05-27 University Of Miami Multimeric tethered ligands and their use in receptor-ligand interactions
EP1060189A1 (de) 1998-02-20 2000-12-20 Advanced Medicine, Inc. Glycopeptid-derivate als antibakterielle mittel
WO1999064032A1 (en) 1998-06-08 1999-12-16 Advanced Medicine, Inc. Combinatorial synthesis of multibinding libraries
US6335155B1 (en) 1998-06-26 2002-01-01 Sunesis Pharmaceuticals, Inc. Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules

Also Published As

Publication number Publication date
EP1350108A2 (de) 2003-10-08
DE60211849D1 (de) 2006-07-06
US6656694B2 (en) 2003-12-02
WO2002056016A2 (en) 2002-07-18
AU2002239882A1 (en) 2002-07-24
JP2005501218A (ja) 2005-01-13
JP4111830B2 (ja) 2008-07-02
WO2002056016A3 (en) 2003-02-06
EP1350108B1 (de) 2006-05-31
US20020090645A1 (en) 2002-07-11
DE60211849T2 (de) 2006-11-23

Similar Documents

Publication Publication Date Title
DE60211849D1 (de) Verfahren zur Identifizierung von Liganden eines biologischen Substrats
DE69822949D1 (de) Verfahren zur quantitativen Messung eines Substrats
DE69228421D1 (de) Substrat für oberflächenverstärkte verfahren und für spezifische verfahren hergestellte substrate
DE60041355D1 (de) Verfahren zur detektion von erkrankungen
DE59814295D1 (de) Verfahren zur Analytbestimmung unter Verwendung eines universellen Analysenelementes
DE60328885D1 (de) Verfahren zur Beurteilung eines Krankheitzustandes mittels Nachweis von partikel- und nicht partikelgebundenen Nukleinsäuren in Blutplasma und -serum
ATE270429T1 (de) Verfahren und vorrichtung zur erkennung von molekül-bindungsreaktionen
ATE431553T1 (de) Verfahren zum nachweis von analyten durch magnetischen teilchen
ATE378404T1 (de) Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon
DE602004010432D1 (de) Verfahren zur beurteilung rheumatoider arthritis durch messen von anti-ccp und interleukin 6
ATE350659T1 (de) Verfahren zur identifizierung von proben eines säugetiers als auch ein kit zur durchführung des verfahrens
DE69604920D1 (de) Verwendung einer phycobiliprotein-peptidkomplexverbindung als fluoreszenzlabel
DE60213256D1 (de) Verfahren zur bestimmung von mehrere analyten
ATE115728T1 (de) Verfahren zur verminderung von störungen in einer fluoreszenzbestimmung.
DE60310012D1 (de) Verfahren, Assay und Kit zur Quantifizierung von HIV-Proteasehemmer
DE60037864D1 (de) Enzymhemmungsimmunverfahren
DE69836713D1 (de) Verfahren zur Verbesserung der Genauigkeit von der semi-quantitativen Bestimmung eines Analyts in flüssigen Proben
ATE471989T1 (de) Verfahren zur identifizierung einer auf einen körper aufgebrachten markierung
ATE354800T1 (de) Verfahren zum nachweiss von antikörpern in einer probe
ATE359512T1 (de) Biochemisches verfahren und vorrichtung zur bestimmung von eigenschaften von proteinen
ATE310948T1 (de) Verfahren und sonde zur identifizierung eines polymers
ATE270919T1 (de) Verfahren zum fixieren von bio-molekülen an eine probestelle
ATE323282T1 (de) VERFAHREN ZUR BESTIMMUNG EINES ERHÖHTEN RISIKOS EINER FRAU, EIN FOETUS MIT DEM ßDOWN-SYNDROMß ZU TRAGEN
ATE426807T1 (de) Proteomanalyse verfahren zum drogen vergleich
ATE465407T1 (de) Verfahren zum spezifischen nachweis von legionella pneumophila

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties